# Apple

Organization · id `cardio:apple` · Cardiovascular Atlas · release `5dcd9b263fe17744` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

Also called: Apple Inc.

Browse, condition area: Heart rhythm problems  

## In plain language

A company. It sponsored the Apple Heart Study, and it is the applicant named in the US De Novo decision for the Irregular Rhythm Notification Feature.

## Technical summary

ClinicalTrials.gov NCT03335800 lists Apple Inc. as lead sponsor, with sponsor class INDUSTRY. The abstract of the main paper says the study was funded by Apple, and the openFDA De Novo record DEN180042 names Apple, Inc. as applicant. The regulator's database page calls it the requester. ROR record 059hsda18 lists Apple (United States) as a company and funder.

## Connected pages

- Manufactures: Irregular Rhythm Notification Feature (Apple) (`cardio:apple-irregular-rhythm-notification`)
- Sponsors: Apple Heart Study (`cardio:apple-heart-study`)

## Provenance

Content hash: e5054d9690e6939c298957b97d6d24aed227027e8757962adf61488271afd256
Last substantive edit: 2026-10-15
Evidence last checked: 2026-10-14